Thanks to Honeyman
“We hold that the State of New Mexico is constitutionally required to allow same-gender couples to marry and must extend to them the rights, protections, and responsibilities that derive from civil marriage under New Mexico law” – Justice Chavez, New Mexico Supreme Court, December 19, 2013
This news just broke: The New Mexico Supreme Court affirms that our state constitution affirms the right to marry for same-sex couples!
Every progressive organization in New Mexico, everyone who fights for constitutional protection, economic freedom and protections under the law for every citizen in New Mexico is out on the streets celebrating. My emailbox is filled with folks who worked to press this case. The chimes of freedom ring throughout New Mexico even if the churches of official New Mexico are silent.
Folks who support freedom in New Mexico are fortunate in that many of our elected officials supported this struggle. With the exception of the sole Republican in New Mexico’s delegation to Congress support has been solid. Tom Udall, Martin Heinrich, Ben Ray Lujan and Michelle Lujan Grisham will be at celebrations throughout the state tonight. They’re posting congratulations at various social media sites and I for one will be spending a bit of time, this afternoon, wending my way through to “liking” each one of them.
Here’s a link to the official proclamation from the State Supreme Court.
The British drug maker GlaxoSmithKline will no longer pay doctors to promote its products and will stop tying compensation of sales representatives to the number of prescriptions doctors write, its chief executive said Monday, effectively ending two common industry practices that critics have long assailed as troublesome conflicts of interest.
The announcement appears to be a first for a major drug company — although others may be considering similar moves — and it comes at a particularly sensitive time for Glaxo. It is the subject of a bribery investigation in China, where authorities contend the company funneled illegal payments to doctors and government officials in an effort to lift drug sales…
Under the plan, which Glaxo said would be completed worldwide by 2016, the company will no longer pay health care professionals to speak on its behalf about its products or the diseases they treat “to audiences who can prescribe or influence prescribing,” it said in a statement. It will also stop providing financial support directly to doctors to attend medical conferences, a practice that is prohibited in the United States through an industry-imposed ethics code but that still occurs in other countries. In China, the authorities have said Glaxo compensated doctors for travel to conferences and lectures that never took place.
On one hand, what should we think of doctors who have been taking these bribes – for that is what they are – to influence which pharmaceuticals they prescribe?
On the other hand, perhaps we have simply come to a place and time where pharmaceutical companies are assured of a massive portion of public spending on drugs and medications by the number of politicians they own?